RIPK1 Antikörper (Middle Region)

Produktnummer ABIN926877

Der Kaninchen Polyklonal anti-RIPK1 Antikörper (ABIN926877) detektiert spezifisch RIPK1 in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human und Rind (Kuh).

Kurzübersicht für RIPK1 Antikörper (Middle Region) (ABIN926877)

Target: RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))

Reaktivität: Human, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RIPK1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-RIPK1 Antikörper

Bindungsspezifität: Middle Region

Kreuzreaktivität: Rind (Kuh)

Aufreinigung: Purified

Immunogen: RIPK1 antibody was raised in rabbit using the middle region of RIPK1 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

RIPK1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this RIPK1 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu RIPK1

Target: RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))

Andere Bezeichnung: RIPK1

Hintergrund: FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex. Synonyms: Polyclonal RIPK1 antibody, Anti-RIPK1 antibody, receptor, TNFRSF-interacting serine-threonine kinase 1 antibody.

Pathways: NF-kappaB Signalweg, Apoptose, Caspase Kaskade in der Apoptose, TLR Signalweg, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interaktom, Ubiquitin Proteasome Pathway